209 related articles for article (PubMed ID: 29326882)
1. The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
Pridham KJ; Varghese RT; Sheng Z
Front Oncol; 2017; 7():312. PubMed ID: 29326882
[TBL] [Abstract][Full Text] [Related]
2. PIK3CB/p110β is a selective survival factor for glioblastoma.
Pridham KJ; Le L; Guo S; Varghese RT; Algino S; Liang Y; Fajardin R; Rodgers CM; Simonds GR; Kelly DF; Sheng Z
Neuro Oncol; 2018 Mar; 20(4):494-505. PubMed ID: 29016844
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
Dornan GL; Burke JE
Front Immunol; 2018; 9():575. PubMed ID: 29616047
[TBL] [Abstract][Full Text] [Related]
4. Ligand-selective signal transduction by two endogenous GnRH isoforms involves biased activation of the class I PI3K catalytic subunits p110β, p110γ, and p110δ in pituitary gonadotropes and somatotropes.
Pemberton JG; Stafford JL; Chang JP
Endocrinology; 2015 Jan; 156(1):218-30. PubMed ID: 25343277
[TBL] [Abstract][Full Text] [Related]
5. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
[TBL] [Abstract][Full Text] [Related]
6. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
[TBL] [Abstract][Full Text] [Related]
7. Class I Phosphoinositide 3-Kinase
Mazloumi Gavgani F; Smith Arnesen V; Jacobsen RG; Krakstad C; Hoivik EA; Lewis AE
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544563
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders.
Gross C; Bassell GJ
Front Mol Neurosci; 2014; 7():12. PubMed ID: 24592210
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
Wang P; Kumar P; Wang C; Defea KA
Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
[TBL] [Abstract][Full Text] [Related]
10. Connexin 43 confers chemoresistance through activating PI3K.
Pridham KJ; Shah F; Hutchings KR; Sheng KL; Guo S; Liu M; Kanabur P; Lamouille S; Lewis G; Morales M; Jourdan J; Grek CL; Ghatnekar GG; Varghese R; Kelly DF; Gourdie RG; Sheng Z
Oncogenesis; 2022 Jan; 11(1):2. PubMed ID: 35022385
[TBL] [Abstract][Full Text] [Related]
11. p110δ PI3K as a therapeutic target of solid tumours.
Xenou L; Papakonstanti EA
Clin Sci (Lond); 2020 Jun; 134(12):1377-1397. PubMed ID: 32556179
[TBL] [Abstract][Full Text] [Related]
12. Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer.
Cui B; Tao J; Yang Y
Cell Biochem Biophys; 2012 Jan; 62(1):47-54. PubMed ID: 21910030
[TBL] [Abstract][Full Text] [Related]
13. p110δ PI3 kinase pathway: emerging roles in cancer.
Tzenaki N; Papakonstanti EA
Front Oncol; 2013; 3():40. PubMed ID: 23459844
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase.
Webb LM; Vigorito E; Wymann MP; Hirsch E; Turner M
J Immunol; 2005 Sep; 175(5):2783-7. PubMed ID: 16116162
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic signaling of class I PI3K isoforms.
Denley A; Kang S; Karst U; Vogt PK
Oncogene; 2008 Apr; 27(18):2561-74. PubMed ID: 17998941
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
[TBL] [Abstract][Full Text] [Related]
17. Expression of Phosphoinositide 3-Kinase p110α and p110β Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma.
Kim K; Lee HW
Appl Immunohistochem Mol Morphol; 2018; 26(10):740-748. PubMed ID: 28549032
[TBL] [Abstract][Full Text] [Related]
18. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.
Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L
Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837
[TBL] [Abstract][Full Text] [Related]
19. Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter.
Whitehead MA; Bombardieri M; Pitzalis C; Vanhaesebroeck B
Biochem J; 2012 May; 443(3):857-67. PubMed ID: 22375552
[TBL] [Abstract][Full Text] [Related]
20. VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells.
Bekhite MM; Finkensieper A; Binas S; Müller J; Wetzker R; Figulla HR; Sauer H; Wartenberg M
J Cell Sci; 2011 Jun; 124(Pt 11):1819-30. PubMed ID: 21540297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
